Adam Harrington

Adam Harrington investor and international venture capitalist is the co-founder of the Intellectual Digital Companies (iDC, iDG, iDBB).

[Adam Harrington @AdamHarrington]

Amazing 250!

https://t.co/rvLkCJsNyA

[Adam Harrington @AdamHarrington]

I believe markets are smarter than the press.

[Adam Harrington @AdamHarrington]

I think the world will change so much in the next 3 - 5 years with robotics, AI, space and quantum - that it is nearly impossible to invest as a venture investor because it is impossible to know what things will look like in 7-10years. .

[Adam Harrington @AdamHarrington]

I am so disappointed to have listened to @ben_mckenzie on your show, his description of all cryptos as being scams and stable coins “only” be used for illicit activities was so senseless. And appears to be so unresearched and absolutely based on anger. You are better than that @billmaher

[Adam Harrington @AdamHarrington]

Imagine that. We are producing more oil than Saudi and Russia combined. Add in Venezuela over time - WOW. Understand the implications of this.

[Adam Harrington @AdamHarrington]

Quote from Prof. Dame Pamela Shaw – Professor of Neurology, Honorary Consultant Neurologist at Sheffield Teaching Hospitals NHS Foundation Trust
“MND robs people of their strength and independence with heartbreaking speed – often within just a few years of diagnosis.
Yet science is finally catching up with the disease. The work we have been doing at Sheffield has already been effective such as M102’s early promise of stopping progression of disease and reversal of cells to a healthier state.
The collaboration between academia and the private sector is vital if we are to turn promising discoveries into real treatments.
With partners such as Aclipse Therapeutics and iDG, we are now translating years of laboratory research into clinical progress – and, most importantly, hope for people living with MND.
There is no medical condition more worthy of strong support for the development of disease-modifying therapies, than MND.”

[Adam Harrington @AdamHarrington]

Imagine a world of AI without anything holding it back..? Oh boy! I think thats our world...

[Adam Harrington @AdamHarrington]

*Forbes features iDG’s view on Iran’s market impact*

_*The Longer-Term View_*
Excerpt by Adam Harrington

Not all investors see the current turbulence the same way. Others are looking beyond the immediate disruption. *Adam Harrington, cofounder of Intellectual Digital Global*, sees the Iran war as a potential long-term positive that can ultimately strengthen the overall Middle East and make for a better VC environment globally.

"While we may see minor blips in early-stage valuations or longer sales cycles, there's no true risk-off regime yet," he says, adding that once markets stabilize, this could resolve into a stronger rally, particularly with tailwinds from pro-business policies, sweeping tax-and-spending packages, and likely deregulation.

Rather than halting early-stage venture activity, he argues the current environment is simply enforcing discipline. "Uncertainty slows decisions and stretches time-to-term sheet," he says. "Founders who win now manage burn like adults, raise a bit earlier, and blend equity with non-dilutive options. Wars don't stop innovation, they sharpen the sorting mechanism, quietly rewarding the most resilient companies and prepared founders."

https://t.co/7rKW92WVeX

[Adam Harrington @AdamHarrington]

The greatest truth. https://t.co/5G8QSG2Ajw

[Bull Theory @BullTheoryio]

THIS IS WHY BITCOIN DUMPED NON STOP FROM $126,000 TO $60,000.

Bitcoin has now crashed -53% in just 120 days without any major negative news or event and this is not normal.

Macro pressure plays a role, but it’s not the main reason Bitcoin keeps dumping. The real driver is something much bigger that most people aren’t talking about yet.

Bitcoin’s original valuation model was built on the idea that supply is fixed at 21 million coins and that price moves based on real buying and selling of those coins. In the early cycles, this was mostly true. But today, that structure has changed.

A large share of Bitcoin trading activity now happens through synthetic markets rather than spot markets.

This includes:

• Futures contracts
• Perpetual swaps
• Options markets
• ETFs
• Prime broker lending
• Wrapped BTC
• Structured products

All of these allow exposure to Bitcoin’s price without requiring actual Bitcoin to move on chain. This changes how price is discovered because now selling pressure can come from derivative positioning rather than real holders selling coins.

For example:

If institutions open large short positions in futures markets, price can fall even if no spot Bitcoin is sold.

If leveraged long traders get liquidated, forced selling happens through derivatives, accelerating downside moves. This creates cascade effects where liquidations drive price, not spot supply.

That is why recent sell offs look very structured. You see long liquidation waves, funding flips negative, open interest collapses, all signs that derivatives positioning is driving the move.

So while Bitcoin’s hard cap has not changed, the effective tradable supply influencing price has expanded through synthetic exposure.

Price today reacts to leverage, hedging flows, and positioning, not just spot demand.

Adding to this, there are other factors too driving the current dump.

GLOBAL ASSET SELL-OFF

Right now, selling is not isolated to crypto. Stocks are declining. Gold and silver have seen volatility. Risk assets across markets are correcting.

When global markets move into risk-off mode, capital exits high-risk assets first and crypto sits at the far end of the risk curve. So Bitcoin reacts more aggressively to global sell offs.

MACRO UNCERTAINTY & GEOPOLITICAL RISK

Tensions around global conflicts, especially U.S.–Iran developments, are creating uncertainty.

Whenever geopolitical risk rises, supply chain risks increase, and markets shift toward defensive positioning. That environment is not supportive for risk assets.

FED LIQUIDITY EXPECTATIONS

Markets had been pricing a more dovish liquidity backdrop. But expectations around future policy leadership and liquidity stance have shifted.

If investors believe future Fed policy will be tighter on liquidity even if rates eventually fall, risk assets reprice lower.

ECONOMIC DATA WEAKNESS

Recent economic indicators job market trends, housing demand, credit stress are pointing toward slowing growth conditions. When recession fears rise, markets derisk.

Crypto, being the most volatile asset class, sees outsized downside during those transitions.

STRUCTURED SELLING VS CAPITULATION

Another important observation:

This sell off does not look like panic capitulation. It looks structured.

Consecutive red candles, controlled downside moves, and derivative driven liquidations suggest large entities reducing exposure, not retail panic selling.

When institutional positioning unwinds, it suppresses bounce attempts because dip buyers wait for stability before re-entering.

PUTTING IT ALL TOGETHER

It is a combination of:

• Derivatives driven price discovery
• Synthetic supply exposure
• Global risk-off flows
• Liquidity expectation shifts
• Geopolitical uncertainty
• Weak macro data
• Institutional positioning unwind

Until these pressures stabilize, relief rallies can happen, but sustained upside becomes harder.

[Adam Harrington @AdamHarrington]

https://t.co/5zphfAZDdk

[Adam Harrington @AdamHarrington]

As a New Yorker - and someone who loves NYC - I cannot believe that the financial capital of the world elected a socialist as its representative. It seems a bit like opposite world.

[Adam Harrington @AdamHarrington]

*MND - Must try harder*

An article I wrote for Pharma Times…

Aclipse Therapeutics’ M102 is emerging as a leading, disease-modifying drug for ALS/MND, supported by innovative research at the University of Sheffield and strong preclinical results.

iDG’s backing has helped advance M102 towards human trials, positioning it to potentially slow or reverse disease progression and redefine the treatment landscape for ALS, a frequently devastating disease for athletes and the broader community.

Funding for innovation, not just charity, is essential to beat MND/ALS. iDG’s focus on breakthrough solutions and strategic investment in Aclipse’s M102 helps to ensure that the most promising therapies get the support needed to move quickly from research to the clinic, giving real hope to patients and showing investors the impact of our mission.

https://t.co/QjoXmMiHQb

[Adam Harrington @AdamHarrington]

An article I wrote about collaborative and beneficial investment between the UK and USA. https://t.co/BtYPYlmNi8

[Adam Harrington @AdamHarrington]

Pleased to have Investment Week share my op-ed.

https://t.co/BtYPYlmNi8

[Adam Harrington @AdamHarrington]

I’m very impressed with Mexico City. I think greater business develops here with the USA. Despite the obvious corruption.

[Adam Harrington @AdamHarrington]

An article I wrote for the London Daily News
*The strengths and challenges of the UK economy: A U.S. perspective*| London Daily News

https://t.co/ZOIFlP8IaI

[Adam Harrington @AdamHarrington]

I have a feeling AI and robotics can fix our healthcare problem which in turn could fix the deficit.

[Adam Harrington @AdamHarrington]

I strongly believe the crypto public company era has begun! Circle started it, who will end it?

[Adam Harrington @AdamHarrington]

I predict the back half of this year will be all about AI layoffs happening at all companies.